Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Up 100.9% in April

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totaling 17,577 shares, a growth of 100.9% from the April 15th total of 8,749 shares. Based on an average daily trading volume, of 220,825 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Wall Street Analyst Weigh In

SGIOY has been the topic of a number of recent analyst reports. The Goldman Sachs Group raised shares of Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a report on Wednesday, April 8th. Zacks Research downgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a report on Thursday, April 16th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce”.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shares of OTCMKTS SGIOY opened at $9.70 on Friday. The firm has a 50-day simple moving average of $10.42 and a 200-day simple moving average of $9.79. The stock has a market capitalization of $16.51 billion, a price-to-earnings ratio of 12.13, a price-to-earnings-growth ratio of 0.72 and a beta of 0.10. The company has a quick ratio of 5.21, a current ratio of 5.84 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. Unsponsored ADR has a 52 week low of $7.56 and a 52 week high of $12.00.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its earnings results on Tuesday, May 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.03. The business had revenue of $881.71 million during the quarter, compared to analysts’ expectations of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 14.09%. On average, equities analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.78 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.